Scientific deep-dive
Does Vaping or Nicotine Cause Weight Loss? What Smokers' Data Show
No study shows vaping causes weight loss. Nicotine modestly curbs appetite and raises calorie burn, but smokers who switched to e-cigarettes gained weight, and quitting adds about 4.7 kg in a year. What the evidence shows, and where GLP-1 drugs fit.
No study has shown that vaping makes anyone lose weight. Nicotine, from a vape, a cigarette or a patch, does modestly blunt appetite and raise the calories the body burns, which is why smokers weigh a little less on average than people who have never smoked.[2] But that effect is small, it comes packaged with an addiction, and the few studies that weighed people who switched from cigarettes to e-cigarettes found weight going up, not down.[7] The real weight question for most people is the reverse one: quitting nicotine adds about 4 to 5 kg on average over a year.[1] That gain is worth knowing about and planning for. It is not a reason to keep vaping.
The short answer, by question
| Question | What the evidence shows | How strong |
|---|---|---|
| Does nicotine suppress appetite? | Yes, modestly. Mouse work traced it to the same brain pathway that controls fullness | Mechanism in animals; consistent with human reports |
| Does nicotine burn more calories? | Smoking raised 24-hour energy use about 10% in one chamber study | Eight people, one study |
| Do smokers weigh less? | On average, a little; heavy smokers often weigh more, and smokers carry more belly fat | Large cohorts and genetic studies |
| Does vaping cause weight loss? | No study shows it; switching from cigarettes to vapes was followed by weight gain | Under 1,000 people studied |
| How much weight does quitting add? | About 4.7 kg on average at 12 months, with wide variation | Meta-analysis of 62 studies |
| Can a GLP-1 prevent that gain? | While taken, yes in one trial; the effect was gone a year later | Two small trials; a larger one is recruiting |
What nicotine does to appetite and metabolism
Nicotine works on weight in two ways. The first is energy use. In a Swiss study in 1986, eight healthy smokers spent 24 hours in a sealed metabolic chamber twice, once smoking 24 cigarettes and once not smoking at all, with diet and exercise held the same. On the smoking day they burned 2,445 calories against 2,230, roughly 10% more, while their resting metabolic rate did not change. Urine levels of norepinephrine, a stress hormone, rose, which points to the sympathetic nervous system as the route.[3] That is the source of the often-repeated figure of about 200 extra calories a day. It comes from eight people on one heavy-smoking day.
The second is appetite. A 2011 study in mice found that nicotine switches on a set of receptors in the hypothalamus that activate POMC neurons, the cells that signal fullness through the melanocortin system. Blocking that pathway stopped nicotine from reducing food intake.[4] It is a mouse study, but it matches what smokers have long reported: they eat less while smoking and more after quitting. GLP‑1 drugs act on overlapping brain circuits, which is part of why researchers have tested them in people who smoke.
None of this is specific to cigarettes. The appetite and metabolic effects come from the nicotine, so they should apply to a nicotine vape too. A vape without nicotine has no known mechanism for changing weight at all. For how much a metabolic change of this size matters, the same arithmetic applies as with any drug: see does Ozempic slow your metabolism, which sets out how energy expenditure is measured and why small percentage shifts are easy to overstate.
Smokers weigh less on average, with two catches
A 2008 review in the American Journal of Clinical Nutrition summed up the pattern: the short-term effects of nicotine on energy use and appetite may explain why smokers tend to weigh less than nonsmokers, and why quitting is so often followed by gain.[2] The same review set out two catches.
- Heavy smokers often weigh more, not less. People who smoke the most tend to be heavier than light smokers or nonsmokers. The review put that down to a cluster of habits, such as less activity and a poorer diet, that travel with heavy smoking.[2]
- The fat moves to the middle. Smoking raises insulin resistance and is linked with fat around the waist.[2] Genetic studies, which use inherited differences in how much people smoke to get closer to cause and effect, back this up. In 148,731 people, a gene variant tied to heavier smoking went with a lower BMI among smokers but a larger waist for any given BMI; the authors warned that smoking to control weight may build up central fat.[5] A 2024 analysis using genome-wide data found smoking increased abdominal fat, particularly the visceral fat around the organs.[6]
Visceral fat is the kind most tied to diabetes and heart disease. So the lower number on the scale does not translate into a healthier body shape.
What is known about vaping specifically
Very little. No trial has tested vaping as a way to lose weight, and the studies that weighed vape users were all asking a different question: what happens to weight when a smoker switches to e-cigarettes. A 2025 systematic review found nine papers from eight studies, five of them randomized. Exclusive vape users showed a consistent pattern of weight gain over time, and people using both vapes and cigarettes gained modestly. The reviewers rated the evidence weak because fewer than 1,000 people had been studied in total.[7]
| Study | Who | Weight finding |
|---|---|---|
| Systematic review, 2025 | 8 studies, under 1,000 people | Weight gain over time with exclusive vaping; modest gain with dual use |
| E3 trial reanalysis, 2024 | 257 smokers randomized to nicotine vapes, nicotine-free vapes or counseling | Quitters gained 2.05–2.70 kg at 12 weeks; vape groups gained 0.56 kg more than counseling alone |
| US PATH survey, 2026 | 2,454 adults who tried to quit | Vapers were less likely to quit than people using no aid; those who quit gained similar weight |
In the E3 trial reanalysis, people who kept smoking stayed at about the same weight whatever group they were in. Those who quit gained 2 to 3 kg in 12 weeks, and the e-cigarette groups did not escape it; if anything they gained slightly more than the counseling-only group. The authors concluded that e-cigarettes had minimal effect on post-quit weight gain, with the caveat that the sample was modest.[8] A 2026 analysis of the US PATH survey found that adults who used e-cigarettes to quit were less likely to succeed than those who used no aid at all, and those who did quit had weight gain comparable to people who used nothing.[9]
So swapping cigarettes for a vape does not appear to hold the weight off. That fits the chamber study: some of the extra calories burned may come from the act and pattern of heavy smoking, not only the nicotine level a vape delivers. That last point is inference; no study has put vapers in a metabolic chamber.
People are vaping to control their weight anyway
In an online survey of 459 adult vapers who wanted to lose or hold their weight, 13.5% said they vaped for that reason. They were more likely to be overweight, to restrict calories and to prefer coffee or vanilla flavors. The researchers called it a scientifically unsubstantiated use of e-cigarettes.[10] Among 529 Connecticut high-school students who vaped flavored liquids, 13.8% said they did it for appetite control and 9.3% for weight loss, and those students vaped more often.[11]
Vaping to suppress appetite overlaps with restrictive eating. If you are using nicotine to avoid eating, that is worth raising with a clinician on its own terms; GLP-1 drugs and eating disorders covers how appetite-suppressing drugs interact with disordered eating.
Why vaping for weight is a bad trade
Set the small appetite effect against what comes with it. The CDC’s position is blunt: nicotine is highly addictive, it can harm brain development, which continues until about age 25, and no tobacco product, e-cigarettes included, is safe. The CDC does say e-cigarettes may benefit adult smokers who are not pregnant, but only as a complete substitute for all smoked tobacco.[16] That is a harm-reduction case for people who already smoke, not a case for anyone to start.
The FDA draws the same line between nicotine and smoke: nicotine is what makes tobacco addictive, while the thousands of other chemicals in tobacco smoke are what make it so deadly. The agency also notes that FDA-approved nicotine replacement products are safe and effective.[17] On the heart, a 2016 review by Neal Benowitz, a leading nicotine pharmacologist, concluded that nicotine without smoke carries low cardiovascular risk compared with smoking, at least in short-term use by healthy people, but remains a concern for anyone with heart disease.[15] Nicotine stimulates the sympathetic nervous system, the same route that appears to drive its extra calorie burn.[3]
What quitting does to your weight
The best estimate comes from a 2012 BMJ meta-analysis of 62 studies. People who quit without any medication gained on average 1.1 kg after one month, 2.9 kg after three, 4.2 kg after six and 4.7 kg after twelve. Most of the gain came in the first three months.[1]
Magnitude comparison
Average weight gain after quitting smoking without treatment, by months since quitting. Meta-analysis of 62 studies.[1]
- 1 month1.12 kg
- 2 months2.26 kg
- 3 months2.85 kg
- 6 months4.23 kg
- 12 months4.67 kg
The average hides a wide spread. At a year, about 16% of quitters had lost weight, 37% had gained under 5 kg, 34% had gained 5 to 10 kg, and 13% had gained more than 10 kg. Gains were similar whichever quit medication people used, and similar in people who were especially worried about weight.[1]
Treatments only dent it. A 2021 Cochrane review found nicotine replacement trimmed about half a kilogram from the gain by the end of treatment, and bupropion about a kilogram, but neither showed a clear effect at 12 months. Its overall conclusion was that no intervention had moderate-certainty evidence of a clinically useful effect on long-term weight gain.[12]
The weight gain does not cancel the benefit
The gain is real, and it carries a real short-term cost. In three large US cohorts, recent quitters had a 22% higher risk of type 2 diabetes than people who kept smoking, a risk that peaked five to seven years after quitting, rose with the amount gained, and did not appear in quitters who held their weight. But death from heart disease was lower in every group of quitters, including those who gained more than 10 kg.[13]
| Weight change after quitting | Hazard ratio vs current smokers |
|---|---|
| No gain | 0.69 |
| 0.1 to 5 kg | 0.47 |
| 5.1 to 10 kg | 0.25 |
| More than 10 kg | 0.33 |
The Framingham Offspring Study reached the same conclusion: recent quitters without diabetes had roughly half the cardiovascular risk of smokers, and adjusting for the weight they gained barely changed that.[14] In cohort data, quitting and gaining weight is far better than continuing to smoke.
Where GLP-1 drugs come in
Because GLP‑1 drugs suppress appetite through brain pathways close to the ones nicotine uses, they are an obvious candidate for holding off post-quit weight gain. Three small randomized trials have reported, and a fourth, larger one is under way:
- Dulaglutide, 255 smokers. Added to varenicline for 12 weeks, it turned a 1.9 kg gain on placebo into a 1.0 kg loss, a 2.9 kg difference. It did not change quit rates.[18] The injections stopped at 12 weeks, and by one year the weight difference was 0.35 kg, within the range of no effect.[19]
- Exenatide, 84 smokers. Added to a nicotine patch for six weeks, post-quit weight was 5.6 lb lower than on placebo. This was a pilot.[20]
- Semaglutide, 24 smokers. Over nine weeks it lowered craving and body weight but missed its main smoking endpoints. The participants were not trying to quit.[21]
- Semaglutide 2.4 mg, 177 smokers, recruiting. A trial built specifically to test whether Wegovy-dose semaglutide limits weight gain in quitters with obesity, alongside a nicotine patch, for 28 weeks.[22] It is still recruiting, with results not expected before 2028.[23]
The pattern so far: a GLP‑1 holds the weight while you take it, as it does for weight in general, and the weight comes back after stopping. No GLP‑1 is approved for smoking cessation or for preventing post-quit weight gain. The quit-rate evidence is set out in GLP-1 drugs and quitting smoking, and the wider addiction research in GLP-1 drugs and addiction. For why appetite rebounds when a drug like this stops, see why the appetite comes back.
If you already take a GLP‑1 for weight and you vape or smoke, the drug may soften the gain if you quit, though no finished trial has tested that in people already on a full weight-loss dose. That makes now a reasonable time to bring up quitting with the prescriber. Some people on these drugs also describe less food noise, the constant pull toward eating, which is the same kind of urge nicotine was quieting.
If you are quitting and worried about weight
- Expect most of the gain early. On average, more than half of the year’s gain arrives in the first three months.[1] That is the window to plan meals and activity for.
- Use a proven quit aid. Nicotine replacement and bupropion slightly reduce gain during treatment, and FDA calls approved nicotine replacement products safe and effective.[12][17]
- Do not swap to a vape for weight reasons. The available studies show no weight advantage from switching.[7][8]
- Ask about blood sugar. The diabetes risk after quitting tracked the amount of weight gained,[13] so a check-up in the first few years is sensible for anyone who gains a lot.
- Keep the weight in proportion. In the cohort data, even quitters who gained more than 10 kg had lower heart-disease death than people who kept smoking.[13]
Frequently Asked Questions
References
- 1.Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P. Weight gain in smokers after quitting cigarettes: meta-analysis BMJ. 2012. PMID: 22782848.
- 2.Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance American Journal of Clinical Nutrition. 2008. PMID: 18400700.
- 3.Hofstetter A, Schutz Y, Jéquier E, Wahren J. Increased 24-hour energy expenditure in cigarette smokers New England Journal of Medicine. 1986. PMID: 3941694.
- 4.Mineur YS, Abizaid A, Rao Y, et al. Nicotine decreases food intake through activation of POMC neurons Science. 2011. PMID: 21659607.
- 5.Morris RW, Taylor AE, Fluharty ME, et al. Heavier smoking may lead to a relative increase in waist circumference: evidence for a causal relationship from a Mendelian randomisation meta-analysis. The CARTA consortium BMJ Open. 2015. PMID: 26264275.
- 6.Carrasquilla GD, García-Ureña M, Romero-Lado MJ, Kilpeläinen TO. Estimating causality between smoking and abdominal obesity by Mendelian randomization Addiction. 2024. PMID: 38509034.
- 7.La Rosa GRM, Polosa R, O'Leary R. Effect of E-Cigarette Substitution for Cigarettes on Weight Status: A Systematic Review Archives of Medical Research. 2025. PMID: 40174301.
- 8.Lyzwinski L, Dong M, Wolfinger RD, Filion KB, Eisenberg MJ. e-Cigarettes, Smoking Cessation, and Weight Change: Retrospective Secondary Analysis of the Evaluating the Efficacy of e-Cigarette Use for Smoking Cessation Trial JMIR Public Health and Surveillance. 2024. PMID: 39283667.
- 9.Murphy CM, Sokolovsky AW, Cooper C, Micalizzi L. The impact of cessation aids on sustained quitting and weight gain among adults with a quit attempt in the PATH study Nicotine & Tobacco Research. 2026. PMID: 42667650.
- 10.Morean ME, Wedel AV. Vaping to lose weight: Predictors of adult e-cigarette use for weight loss or control Addictive Behaviors. 2017. PMID: 27875790.
- 11.Morean ME, Bold KW, Kong G, et al. High school students' use of flavored e-cigarette e-liquids for appetite control and weight loss Addictive Behaviors. 2020. PMID: 31704428.
- 12.Hartmann-Boyce J, Theodoulou A, Farley A, et al. Interventions for preventing weight gain after smoking cessation Cochrane Database of Systematic Reviews. 2021. PMID: 34611902.
- 13.Hu Y, Zong G, Liu G, et al. Smoking Cessation, Weight Change, Type 2 Diabetes, and Mortality New England Journal of Medicine. 2018. PMID: 30110591.
- 14.Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes JAMA. 2013. PMID: 23483176.
- 15.Benowitz NL, Burbank AD. Cardiovascular toxicity of nicotine: Implications for electronic cigarette use Trends in Cardiovascular Medicine. 2016. PMID: 27079891.
- 16.Centers for Disease Control and Prevention Health Effects of Vaping CDC, Smoking and Tobacco Use. 2025. https://www.cdc.gov/tobacco/e-cigarettes/health-effects.html
- 17.U.S. Food and Drug Administration Nicotine Is Why Tobacco Products Are Addictive FDA, Center for Tobacco Products. 2026. https://www.fda.gov/tobacco-products/health-effects-tobacco-use/nicotine-why-tobacco-products-are-addictive
- 18.Lengsfeld S, Burkard T, Meienberg A, et al. Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial EClinicalMedicine. 2023. PMID: 36874396.
- 19.Lüthi H, Lengsfeld S, Burkard T, et al. Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial EClinicalMedicine. 2024. PMID: 38371479.
- 20.Yammine L, Green CE, Kosten TR, et al. Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial Nicotine & Tobacco Research. 2021. PMID: 33831213.
- 21.Hendershot CS, Bremmer MP, Paladino MB, et al. Once-Weekly Semaglutide in Adults With Daily Cigarette Use: A Randomized Clinical Trial JAMA Network Open. 2026. PMID: 42189538.
- 22.Yammine L, Leidy H, Maki KC, et al. A randomized controlled trial of once-weekly semaglutide for limiting post-smoking cessation weight gain in smokers with overweight/obesity: Study protocol Contemporary Clinical Trials. 2025. PMID: 40554081.
- 23.ClinicalTrials.gov Semaglutide for Post-Smoking Cessation Weight Management (NCT06173778) U.S. National Library of Medicine. 2026. https://clinicaltrials.gov/study/NCT06173778
Compare the sellers
Related research
Five Hundred Calories at One Lunch
Researchers weighed what 114 people ate at a free-access lunch. Three weeks into tirzepatide they ate 524.6 fewer calories, without any increase in conscious dietary restraint.
6 min read
Taste Got Better, Not Worse
People on these drugs routinely say food tastes wrong. A trial measured taste objectively, biopsied participants' tongues and scanned their brains, and found taste recognition improved.
6 min read
Jardiance and Farxiga for Weight Loss: How Much, and Why It Stops
Jardiance and Farxiga cause about 2 kg of weight loss in type 2 diabetes and less without it, and neither is approved for weight. Why appetite cancels most of the sugar lost in urine, the side effects, and how they compare with Wegovy and Zepbound.
10 min read
AOD-9604: What the Evidence Shows
AOD-9604, a growth hormone fragment, failed its obesity trials: in 536 adults, weight loss beyond placebo was under 1 kg and the developer ended the program in 2007. FDA advisers voted 12 to 0 against compounding it.
9 min read
Beyond the Scale: Blood Pressure, Lipids and What Else Changes
Pooling the individual records of 3,136 people, systolic blood pressure fell 4.95 mmHg further than placebo, and by about the same amount whether or not the person had hypertension.
7 min read
Bimagrumab Plus Semaglutide: The Muscle Question
The combination lost 17.8 kg at 48 weeks against 14.2 kg for semaglutide alone. But bimagrumab exists to change what you lose, and the published summary reports only how much.
6 min read
Where to get semaglutide (Ozempic / Wegovy) online, safely: sellers our editors have checked
These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
MEDGm
Compounded semaglutide with every plan price published and the partner pharmacies named
From $299/mo
Get started →HumeCare+
An oral route if you will not self-inject
From $199/mo
Get started →Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →